New guidelines issued for genetic screening in newborns, children

February 21, 2013 by Denise Mann, Healthday Reporter
New guidelines issued for genetic screening in newborns, children
Panel backs testing for childhood diseases, but defers to parents' wishes on diseases that strike in adulthood.

(HealthDay)— New guidelines on testing newborns and children for genetic diseases recommend screening for childhood diseases but note that testing for diseases that strike in adulthood may not be worthwhile.

About 4 million infants in the United States undergo newborn screening each year, but further —while increasingly available—is less common. Newborn screening panels vary from state to state.

All should be tested for the that are included in their state's newborn screening panel, but anything beyond that is up to parents and the decision must be made in the child's best interest, according to the revised policy statement from the American Academy of Pediatrics and the American College of Medical Genetics and Genomics. The new guidelines are published online Feb. 21 in the journal Pediatrics.

The recommendations distinguish between genetic testing for childhood-onset conditions versus those for adult-onset conditions. For kids who may be at risk for a childhood disease, testing is worth considering, the guidelines state, but the same does not hold true if the child is thought to be at risk for a disease that strikes in adulthood.

"There is an important role for counseling before and after genetic screening," added policy author Dr. Lainie Friedman Ross, a and at the University of Chicago. "The focus should be on education of families, counseling them and helping them make decisions that focus on the child's best interest."

The new guidelines do not call for any specific genetic tests; instead they recommend mandatory offering of state newborn screening panels. "We believe that if parents are informed that the benefits outweigh the risks, that they will give their permission, given that all states screen for at least the uniform panel and it is included in costs of birth hospitalization," Friedman Ross said.

Testing for disease in the presence of symptoms is another area addressed by the new recommendations. "Clearly, if a child has symptoms, we need a diagnosis to help the family make clinical decisions that are in the child's best interest. This is important even when the disease has no current therapies," Friedman Ross added.

Kids should also be informed of the results when they reach an appropriate age, she added.

The guideline authors caution against using direct-to-consumer tests, because there is no oversight and the results are open to interpretation.

Pediatricians and geneticists said they are on board with the new recommendations.

"In newborns, we look for things that are treatable and have interventions that will have a significant impact on the child," said Dr. Marshall Summar, division chief of genetics and metabolism at Children's National Medical Center in Washington, D.C.

But "it's a moving target," he said. "We have to constantly reassess this as the technology and our understanding of what the results mean changes."

There are risks when it comes to broad-based gene screens outside of traditional panels, said Dr. Parul Jayakar, a clinical and metabolic geneticist at Miami Children's Hospital. "We may find things that never come to fruition or results that we can't fully interpret yet," he explained.

However, there are also cases were being forewarned is being forearmed, said Dr. Joyce Fox, a doctor at North Shore University in Manhasset, N.Y.

If there is a family history of a genetic disease, even adult-onset ones, there are some instances where knowing this early will make a difference. This includes certain cancers, including a rare type of inherited colon cancer. "We would want the information earlier so we can do appropriate surveillance on the children and prevent the onset of significant disease," Fox said.

But it should be buyer beware when it comes to direct-to-consumer gene screens, she said.

"We highly discourage these even on adults, and particularly on children, because there is nobody there to provide counseling and interpretation," Fox said. These can also be very costly, and are likely not covered by insurance."

Explore further: Parents seen as critical stakeholders in expanding newborn screening

More information: Learn more about newborn screening at the U.S. National Institutes of Health.

Related Stories

Parents seen as critical stakeholders in expanding newborn screening

June 21, 2012
Parents must be considered when states decide to expand genetic screening programs for newborns, according to a new study that looked at mandatory testing panels and political pressure by advocacy groups.

Study: Parents likely to embrace predictive genetic testing for their children if offered

April 18, 2011
Parents offered genetic testing to predict their risks of common, adult-onset health conditions say they would also test their children. That is the finding of a new study published in the May issue of Pediatrics (published ...

State's newborn screening program saved twins' lives

January 9, 2012
(Medical Xpress) -- Like a half-million other babies born in California in 2010, Sophia and Charlotte Gonzales each had a blood sample collected after their birth for the state’s newborn screening program. But in this ...

New guidelines for cardiovascular genetic testing

May 6, 2011
An international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the ...

Recommended for you

Researchers identify new genetic disorder

September 21, 2018
Researchers from Michigan State University College of Human Medicine and physicians from Spectrum Health have identified for the first time in a human patient a genetic disorder only previously described in animal models.

Test could detect patients at risk from lethal fungal spores

September 20, 2018
Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

Researchers identify a new cause of childhood mitochondrial disease

September 20, 2018
A rapid genetic test developed by Newcastle researchers has identified the first patients with inherited mutations in a new disease gene.

Why some human genes are more popular with researchers than others

September 18, 2018
Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in ...

Class of neurological disorders share 3-D genome folding pattern, study finds

September 18, 2018
In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or ...

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer

September 18, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.